With a growing global network, Ardena operates six strategically located facilities across Europe and the US, along with commercial offices in key global regions. Our state-of-the-art facilities are engineered to support early-phase development for oral drugs, injectables, and nanomedicines
Kleimoer 4, Ghent, Belgium
14 School House Road, Somerset, NJ, USA
Kloosterstraat 9, 5349 AB Oss, Netherlands
Tallvägen 6, 151 38 Södertälje, Sweden
Calle Noáin, 1, Noáin, Spain
W.A. Scholtenstraat 7, 9403 AJ Assen, Netherlands
Alderley Park, Congleton Road, Nether Alderley, Macclesfield SK10 4TG, UK
53 Yeongudanji-ro, Ochang-eup, Cheongwon-gu, Cheongju-si, Chungcheongbuk-do, South Korea
Our headquarters and a hub for drug product development and manufacturing, Ardena Ghent is home to 110+ employees. This site also houses our CMC Regulatory team, providing specialist expertise and tailored services to support customers from pre-clinical to clinical manufacturing. With a focus on injectable and oral drugs—particularly those with low solubility challenges—our site in Ghent is a center of excellence for drug products, clinical logistics, and CMC regulatory services.
Ardena’s Somerset facility in New Jersey is a strategic addition to our global network, housing over 200 employees and serving as a Center of Excellence for advanced oral dosage forms. This state-of-the-art site specializes in technologies such as Hot Melt Extrusion, enhancing the bioavailability of poorly soluble drugs, with capabilities to handle controlled substances. Located in the heart of New Jersey, the facility supports late-stage and small-scale commercial manufacturing, complementing our existing oral solid expertise. This expansion strengthens our U.S. presence and enhances our ability to provide comprehensive drug development solutions across the entire pharmaceutical lifecycle.
Ardena counts with two sites in Oss situated on Pivot Park, a renowned Life Sciences campus in the Netherlands focused on pharmaceutical innovation. With over 165 employees from more than 10 nationalities, our team specializes in developing and manufacturing Active Pharmaceutical Ingredients (APIs) and nanomedicines as well as providing advanced Solid State Research Services. Our API plant and solid state research lab, as well as our state-of-the art nanomedicine site are capable of handling highly potent compounds. With cutting-edge facilities and a global client base, Oss is a dynamic environment for scientific breakthroughs.
Ardena Södertälje has a team of 45+ employees from 17 nationalities. This site specializes in API production and development, bringing dozens of Active Pharmaceutical Ingredients (APIs) from early lead molecules to clinical studies. With a collaborative culture, our site in Södertälje is a center of excellence for API production and development.
Ardena’s site in Pamplona specializes in oral solid drug development and manufacturing, with expertise in highly potent compounds and spray-drying technology to enhance the bioavailability of poorly soluble drugs. With a growing scientific and operations team of 115+, we focus on niche oncology treatments and orphan drugs, making a real difference for patients worldwide.
Ardena Assen is a highly specialized and innovative facility offering a full range of bioanalytical services from drug discovery research to phase IV clinical studies. With advanced labs and a team of 90+ experts, we specialize in analyzing small molecules, proteins, vaccines, and more, delivering precision science in an inspiring, collaborative atmosphere.
Located in the heart of one of the UK’s most renowned life sciences hubs, our commercial office at Alderley Park positions Ardena at the forefront of the British pharmaceutical and biotech industries. This office focuses on building relationships with regional partners and providing tailored consultations on Ardena’s comprehensive drug development expertise, ensuring clients in the UK benefit from local access to our services.
Ardena’s commercial office in Cheongju is a key point of contact for clients across the Asia-Pacific region. Situated within South Korea’s growing biotech landscape, this office is dedicated to supporting collaborations and providing local access to our global CDMO and bioanalytical CRO capabilities, ensuring that companies in the region benefit from Ardena’s specialized expertise and services.
Using the right standards at the right development phase, our comprehensive program management services streamline your small molecule drug development.
Helping you turn your compounds that show promise into GMP-grade drug substances.
We advance your clinical candidates through the pipeline quickly and safely with specialist drug product services.
Our bioanalytical platform supports your preclinical and clinical stages with expert testing services.
Our comprehensive CMC regulatory services streamline preparation and submission of your registration file.
Using the right standards at the right development phase, our comprehensive program management services streamline your large molecule drug development.
We advance your large molecule candidates through the pipeline quickly and safely with specialist drug product services.
Our bioanalytical platform supports your large molecule drugs through preclinical and clinical stages with expert testing services.
Our comprehensive CMC regulatory services streamline the preparation and submission of the regulatory files for your large molecule drug.
Using the right standards at the right development phase, our comprehensive program management services streamline your nanomedicine drug development.
We turn your nanomedicine candidates into suitable drugs with specialist development and manufacturing services.
Our bioanalytical platform supports your preclinical and clinical stages with expert testing services.
Our comprehensive CMC regulatory services streamline the preparation and submission of the regulatory files for your nanomedicines.
We have a deep understanding and exceptional experience which we leverage to guide our approach and deliver the best possible outcomes for our partners.
Get in touch to see how we can craft your path to the clinic with dedicated capabilities.